IFRX

InflaRx N.V. NASDAQ Listed Nov 7, 2017

Healthcare ·Biotechnology ·DE · inflarx.de

$2.50

After hrs $2.59 +3.60%

Mkt Cap $180.7M

52w Low $0.71 83.2% of range 52w High $2.86

50d MA $1.17 200d MA $1.14

P/E (TTM) -3.2x

EV/EBITDA -0.9x

P/B 3.4x

Debt/Equity 0.0x

ROE —

P/FCF -1.7x

RSI (14) —

ATR (14) —

Beta 1.51

50d MA $1.17

200d MA $1.14

Avg Volume 598.8K

About

InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a novel intravenously delivered first-in-class anti-C5a mo…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Mar 19, 2026	AMC	-0.18	-0.17	+5.6%	0.91	-2.2%	+3.3%	+6.4%	+12.1%	+3.4%	+2.2%	—
Nov 10, 2025	AMC	-0.16	-0.16	+0.0%	1.58	+5.1%	+4.4%	-7.6%	-19.6%	-14.6%	-21.5%	—
Aug 7, 2025	AMC	-0.24	-0.24	+0.0%	0.82	+0.9%	-1.8%	+1.0%	+2.2%	+0.1%	+1.5%	—
May 7, 2025	AMC	-0.18	-0.14	+22.2%	1.49	+2.0%	+6.0%	+8.1%	+12.1%	+20.1%	+23.5%	—
Mar 20, 2025	AMC	-0.27	-0.09	+66.7%	1.26	+0.0%	+1.6%	+11.9%	+5.6%	-1.6%	-0.8%	—
Nov 8, 2024	AMC	-0.27	-0.33	-22.2%	1.56	-1.9%	-1.9%	-3.2%	+9.6%	+30.1%	+25.0%	—
Aug 8, 2024	AMC	-0.21	-0.26	-23.8%	1.34	+7.5%	+3.0%	+1.5%	+3.0%	+0.7%	+0.7%	—
May 8, 2024	AMC	-0.24	-0.19	+20.8%	1.20	+8.3%	+0.0%	-1.7%	+4.2%	+19.2%	+16.7%	—
Mar 21, 2024	AMC	-0.20	-0.30	-50.0%	1.54	-0.6%	-3.2%	+0.0%	+0.0%	+0.0%	+0.0%	—
Nov 1, 2023	AMC	-0.29	-0.14	+51.7%	1.62	+0.0%	-13.6%	-14.8%	-15.4%	-8.6%	-12.3%	—
Aug 10, 2023	AMC	-0.36	-0.15	+58.3%	4.00	+0.0%	-5.5%	-8.8%	-13.8%	-15.5%	-5.2%	—
May 11, 2023	AMC	-0.30	-0.27	+10.0%	4.90	+0.4%	+4.1%	-1.2%	-0.2%	-3.1%	-10.8%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Apr 24	Oppenheimer	Reiterates	Outperform	$5	$1.56	$1.61	+3.2%	-5.1%	+3.2%	+7.1%	+26.9%	+32.7%
Apr 21	Guggenheim	Maintains	Buy → Buy	—	$1.66	$1.65	-0.6%	+4.2%	-3.6%	-6.0%	-10.8%	-3.0%
Mar 20	Guggenheim	Maintains	Buy → Buy	—	$0.91	$0.89	-2.2%	+3.3%	+6.4%	+12.1%	+3.4%	+2.2%
Dec 30	HC Wainwright & Co.	Maintains	Buy → Buy	—	$1.02	$0.99	-2.9%	+0.0%	-1.0%	+6.9%	+11.8%	+14.7%
Dec 3	Leerink Partners	Downgrade	Outperform → Market Perform	—	$0.99	$1.00	+0.6%	+2.6%	+10.7%	+6.6%	+6.6%	+6.6%
Nov 10	Guggenheim	Maintains	Buy → Buy	—	$1.23	$1.77	+43.9%	+28.5%	+34.1%	+18.7%	+3.3%	+9.8%
May 29	Oppenheimer	Maintains	Outperform → Outperform	—	$0.73	$0.77	+5.4%	+16.4%	+9.9%	+10.9%	+20.5%	+16.4%
Mar 26	Guggenheim	Maintains	Buy → Buy	—	$1.33	$1.35	+1.5%	-6.8%	-6.0%	-13.5%	-23.3%	-21.1%
Mar 21	HC Wainwright & Co.	Maintains	Buy → Buy	—	$1.26	$1.26	+0.0%	+1.6%	+11.9%	+5.6%	-1.6%	-0.8%
Mar 7	HC Wainwright & Co.	Maintains	Buy → Buy	—	$1.21	$1.25	+3.3%	+0.0%	-1.7%	-2.5%	+1.7%	-5.0%
Jan 16	HC Wainwright & Co.	Maintains	Buy → Buy	—	$2.52	$2.53	+0.4%	+1.2%	+0.8%	-2.0%	-0.8%	-6.0%
Dec 20	HC Wainwright & Co.	Maintains	Buy → Buy	—	$2.13	$2.08	-2.3%	+5.2%	+17.4%	+17.8%	+22.5%	+21.6%
Nov 15	HC Wainwright & Co.	Maintains	Buy → Buy	—	$2.03	$2.18	+7.4%	-3.9%	-14.3%	-5.4%	+0.5%	+1.5%
Nov 11	HC Wainwright & Co.	Maintains	Buy → Buy	—	$1.56	$1.53	-1.9%	-1.9%	-3.2%	+9.6%	+30.1%	+25.0%
Sep 25	HC Wainwright & Co.	Maintains	Buy → Buy	—	$1.54	$1.57	+1.9%	-1.3%	+0.0%	+1.9%	-0.6%	-1.9%
Jun 24	HC Wainwright & Co.	Maintains	Buy → Buy	—	$1.54	$1.58	+2.6%	+8.4%	+5.2%	+3.9%	+8.4%	+13.0%
Jun 6	HC Wainwright & Co.	Maintains	Buy → Buy	—	$1.58	$1.64	+3.8%	+1.9%	+1.9%	+0.0%	-1.3%	+0.6%
May 9	HC Wainwright & Co.	Maintains	Buy → Buy	—	$1.20	$1.30	+8.3%	+0.0%	-1.7%	+4.2%	+19.2%	+16.7%
Mar 22	HC Wainwright & Co.	Maintains	Buy → Buy	—	$1.54	$1.53	-0.6%	-3.2%	+0.0%	+0.0%	+0.0%	+0.0%
Jan 25	HC Wainwright & Co.	Maintains	Buy → Buy	—	$1.60	$1.68	+5.0%	-6.2%	-3.8%	+7.5%	+3.1%	+1.2%
Nov 2	Raymond James	Maintains	Strong Buy → Strong Buy	—	$1.62	$1.62	+0.0%	-13.6%	-14.8%	-15.4%	-8.6%	-12.3%
Sep 12	HC Wainwright & Co.	Maintains	Buy → Buy	—	$4.00	$4.00	+0.0%	-0.5%	-2.8%	-3.5%	-5.5%	-11.5%
Aug 31	HC Wainwright & Co.	Maintains	Buy → Buy	—	$4.11	$4.02	-2.2%	-3.9%	+1.0%	-1.0%	+0.5%	-4.6%
Aug 11	HC Wainwright & Co.	Maintains	Buy → Buy	—	$4.00	$4.00	+0.0%	-5.5%	-8.8%	-13.8%	-15.5%	-5.2%
May 12	Raymond James	Maintains	Strong Buy → Strong Buy	—	$4.90	$4.92	+0.4%	+4.1%	-1.2%	-0.2%	-3.1%	-10.8%
May 12	HC Wainwright & Co.	Maintains	Buy → Buy	—	$4.90	$4.92	+0.4%	+4.1%	-1.2%	-0.2%	-3.1%	-10.8%
Apr 21	HC Wainwright & Co.	Maintains	Buy → Buy	—	$4.70	$4.62	-1.7%	-4.7%	+1.3%	+0.0%	-0.4%	-1.1%
Apr 6	Raymond James	Maintains	Strong Buy → Strong Buy	—	$6.10	$5.99	-1.8%	-9.8%	-18.9%	-18.4%	-32.8%	-28.5%
Apr 5	HC Wainwright & Co.	Maintains	Buy → Buy	—	$3.77	$5.01	+32.9%	+61.8%	+45.9%	+31.3%	+32.1%	+8.8%
Apr 5	LifeSci Capital	Upgrade	Market Perform → Outperform	—	$3.77	$5.01	+32.9%	+61.8%	+45.9%	+31.3%	+32.1%	+8.8%
Apr 5	Guggenheim	Upgrade	Neutral → Buy	—	$3.77	$5.01	+32.9%	+61.8%	+45.9%	+31.3%	+32.1%	+8.8%
Jan 6	HC Wainwright & Co.	Maintains	Buy → Buy	—	$2.92	$3.01	+3.1%	-3.8%	-9.6%	-8.9%	-8.6%	-4.5%
Nov 10	Raymond James	Maintains	Strong Buy → Strong Buy	—	$2.68	$2.70	+0.7%	-4.1%	+0.0%	-8.6%	-4.1%	-6.0%
Aug 8	HC Wainwright & Co.	Maintains	Buy → Buy	—	$2.91	$3.08	+5.8%	+6.9%	+4.5%	+7.9%	+4.5%	+2.7%
May 13	Credit Suisse	Maintains	Underperform → Underperform	—	$1.46	$1.59	+8.9%	+0.0%	-4.8%	+1.4%	-1.4%	+2.7%
May 13	HC Wainwright & Co.	Maintains	Buy → Buy	—	$1.46	$1.59	+8.9%	+0.0%	-4.8%	+1.4%	-1.4%	+2.7%
May 13	Raymond James	Maintains	Strong Buy → Strong Buy	—	$1.46	$1.59	+8.9%	+0.0%	-4.8%	+1.4%	-1.4%	+2.7%
May 12	SVB Leerink	Maintains	Outperform → Outperform	—	$1.37	$1.36	-0.7%	+6.6%	+6.6%	+1.5%	+8.0%	+5.1%
Mar 25	SVB Leerink	Maintains	Outperform → Outperform	—	$2.47	$2.50	+1.2%	+1.6%	-5.3%	-6.5%	-3.2%	-25.9%
Nov 8	Raymond James	Maintains	Strong Buy → Strong Buy	—	$4.65	$4.50	-3.2%	+0.2%	+5.8%	+0.4%	+5.6%	+20.0%
Oct 28	Raymond James	Upgrade	Outperform → Strong Buy	—	$2.86	$4.24	+48.3%	+42.0%	+48.3%	+65.7%	+74.5%	+70.6%
Aug 6	Credit Suisse	Maintains	Underperform → Underperform	—	$2.58	$2.56	-0.8%	+1.6%	+2.3%	-0.8%	-3.9%	-4.7%
Aug 6	Raymond James	Maintains	Outperform → Outperform	—	$2.58	$2.56	-0.8%	+1.6%	+2.3%	-0.8%	-3.9%	-4.7%
May 13	Credit Suisse	Maintains	Underperform → Underperform	—	$2.85	$2.91	+2.1%	-4.6%	-2.1%	-3.5%	-4.2%	-0.4%
May 13	Raymond James	Maintains	Outperform → Outperform	—	$2.85	$2.91	+2.1%	-4.6%	-2.1%	-3.5%	-4.2%	-0.4%
Mar 26	HC Wainwright & Co.	Maintains	Buy → Buy	—	$3.89	$3.96	+1.8%	+4.4%	-6.9%	-2.6%	+0.3%	+3.9%
Mar 11	Guggenheim	Upgrade	Neutral → Buy	—	$4.45	$4.81	+8.1%	+6.3%	+7.6%	+8.1%	+5.4%	+5.8%
Jan 12	HC Wainwright & Co.	Maintains	Buy → Buy	—	$5.74	$5.96	+3.8%	+8.7%	+9.9%	+5.1%	-3.1%	+2.8%
Nov 6	SVB Leerink	Upgrade	Market Perform → Outperform	—	$4.15	$4.30	+3.6%	+6.3%	-1.9%	-4.3%	-1.2%	-1.7%
Oct 8	HC Wainwright & Co.	Maintains	Buy → Buy	—	$4.56	$4.74	+3.9%	+2.6%	+6.4%	+6.8%	+5.5%	+10.7%

Data updated apr 25, 2026 3:04pm · Source: massive.com